MedPath
NMPA Approval

Selegiline Hydrochloride Tablets

国药准字H20234721

March 6, 2024

Drug Information

盐酸司来吉兰片

片剂

5mg

化学药品

March 6, 2024

Company Information

Applicant Company

安徽省合肥市高新技术开发区红枫路30号

Manufacturing Company

合肥市高新技术开发区红枫路30号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸司来吉兰片 - NMPA 批准文号 | MedPath